A Study to Evaluate the Effect of Food, Formulation, and a Proton Pump Inhibitor (PPI) on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-003)
Clinical trial NCT06619314 · COMPLETED
Trial details
- NCT number
- NCT06619314
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-20
- Primary completion
- 2023-11-25
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.